Basiliximab in a Triple-Drug Regimen With Tacrolimus and Steroids in Liver Transplantation

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients

Björn Nashan, Richard H. Moore, P L Amlot et al. · The Lancet · 1997 · 762 citations

Life Sciences, Immunology, Nephrology +15

REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2

Barry D. Kahan, P. R. Rajagopalan, Michael Hall · Transplantation · 1999 · 483 citations

Life Sciences, Immunology, Pharmacology +17

A RANDOMIZED, DOUBLE-BLIND TRIAL OF BASILIXIMAB IMMUNOPROPHYLAXIS PLUS TRIPLE THERAPY IN KIDNEY TRANSPLANT RECIPIENTS1,2

Claudio Ponticelli, Alexander Yussim, V. Cambi et al. · Transplantation · 2001 · 144 citations

Pharmacy, Immunology, Pharmacotherapy +17

Primer on Transplantation

Mark D. Stegall · JAMA · 2002 · 139 citations

Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation12

Joseph Lawen, Elizabeth Davies, Georges Mourad et al. · Transplantation · 2003 · 137 citations

Medicine, Immunology, Pharmacology +17